Results 231 to 240 of about 88,264 (269)
Some of the next articles are maybe not open access.
Hematology, 2005
AbstractChronic lymphocytic leukemia (CLL) follows an extremely variable course with survival ranging from months to decades. Recently, there has been major progress in the identification of molecular and cellular markers that may predict the tendency for disease progression in CLL patients.
openaire +2 more sources
AbstractChronic lymphocytic leukemia (CLL) follows an extremely variable course with survival ranging from months to decades. Recently, there has been major progress in the identification of molecular and cellular markers that may predict the tendency for disease progression in CLL patients.
openaire +2 more sources
Hematology, 2008
Abstract Chronic lymphocytic leukemia (CLL) has an extremely heterogeneous clinical course, with some patients requiring immediate therapy and others living without need for treatment for decades. There has been considerable interest in the underlying molecular mechanisms of this heterogeneity to understand not only the expected clinical
openaire +2 more sources
Abstract Chronic lymphocytic leukemia (CLL) has an extremely heterogeneous clinical course, with some patients requiring immediate therapy and others living without need for treatment for decades. There has been considerable interest in the underlying molecular mechanisms of this heterogeneity to understand not only the expected clinical
openaire +2 more sources
Blood, 2010
Elevated plasma levels of the angiogenic factor Ang-2 correlated with poor prognosis in a larger series of CLL patients. Ang-2 levels may reflect crosstalk between CLL cells and their microenvironment, specifically related to angiogenesis and endothelial cells, and therefore emphasize the importance of angiogenesis in CLL. .
openaire +2 more sources
Elevated plasma levels of the angiogenic factor Ang-2 correlated with poor prognosis in a larger series of CLL patients. Ang-2 levels may reflect crosstalk between CLL cells and their microenvironment, specifically related to angiogenesis and endothelial cells, and therefore emphasize the importance of angiogenesis in CLL. .
openaire +2 more sources
2013
The description of apoptosis and the identification of the genes that regulate it have proved pivotal to our understanding of how cancer cells accumulate and ultimately cause morbidity and mortality. It has become increasingly clear that in CLL the balance between the pro- and anti-apoptotic members of the BCL2 family of apoptotic regulatory proteins ...
Chris, Fegan, Chris, Pepper
openaire +2 more sources
The description of apoptosis and the identification of the genes that regulate it have proved pivotal to our understanding of how cancer cells accumulate and ultimately cause morbidity and mortality. It has become increasingly clear that in CLL the balance between the pro- and anti-apoptotic members of the BCL2 family of apoptotic regulatory proteins ...
Chris, Fegan, Chris, Pepper
openaire +2 more sources
Blood, 2011
In this issue of Blood, Danese and colleagues present a large database analysis of patterns of care and outcomes with respect to chemoimmunotherapy for older patients with chronic lymphocytic leukemia (CLL). Their analysis demonstrates some of the important benefits and limitations of health services research as it relates to hematology.
openaire +2 more sources
In this issue of Blood, Danese and colleagues present a large database analysis of patterns of care and outcomes with respect to chemoimmunotherapy for older patients with chronic lymphocytic leukemia (CLL). Their analysis demonstrates some of the important benefits and limitations of health services research as it relates to hematology.
openaire +2 more sources
Inherited Susceptibility to CLL
2013Chronic lymphocytic leukaemia (CLL) is the most common lymphoid malignancy in Western countries, accounting for around a quarter of all leukaemias. Despite a strong familial basis to CLL, with risks in first-degree relatives of CLL cases being increased around sevenfold, the inherited genetic basis of CLL is currently largely unknown.
Helen E, Speedy +2 more
openaire +2 more sources
Blood, 2009
In this issue, Del Giudice and colleagues report on 9 patients with CLL who had a spontaneous regression of their tumors, providing new insights into this intriguing phenomenon.[1][1] It has been known since the 1990s, mainly through anecdotal cases, that cancer can spontaneously regress (ie,
openaire +2 more sources
In this issue, Del Giudice and colleagues report on 9 patients with CLL who had a spontaneous regression of their tumors, providing new insights into this intriguing phenomenon.[1][1] It has been known since the 1990s, mainly through anecdotal cases, that cancer can spontaneously regress (ie,
openaire +2 more sources